首页> 美国卫生研究院文献>Genes Diseases >Anti-endothelial cell antibody rich sera from rheumatic heart disease patients induces proinflammatory phenotype and methylation alteration in endothelial cells
【2h】

Anti-endothelial cell antibody rich sera from rheumatic heart disease patients induces proinflammatory phenotype and methylation alteration in endothelial cells

机译:风湿性心脏病患者富含抗内皮细胞抗体的血清诱导内皮细胞促炎表型和甲基化改变

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Rheumatic heart disease (RHD) is a major cause of cardiovascular morbidity and mortality in developing nations like India. RHD commonly affects the mitral valve which is lined by a single layer of endothelial cells (ECs). The role of ECs in mitral valve damage during RHD is not well elucidated. In here, anti-endothelial cell antibody from RHD patients has been used to stimulate the ECs (HUVECs and HMVECs). ECs proinflammatory phenotype with increased expression of TNFα, IL-6, IL-8, IFNγ, IL-1β, ICAM1, VCAM1, E-selectin, laminin B, and vimentin was documented in both ECs. The promoter hypomethylation of various key inflammatory cytokines (TNFα, IL-6, and IL-8), integrin (ICAM1) associated with leukocyte transendothelial migration, and extracellular matrix genes (vimentin, and laminin) were also observed. Further, the in-vitro data was in accordance with ex-vivo observations which correlated significantly with the etiological factors such as smoking, socioeconomic status, and housing. Thus, the study sheds light on the role of ECs in RHD which is a step forward in the elucidation of disease pathogenesis.
机译:在印度等发展中国家,风湿性心脏病(RHD)是导致心血管疾病发病率和死亡率的主要原因。 RHD通常会影响由单层内皮细胞​​(EC)排列的二尖瓣。尚不完全清楚EC在RHD期间二尖瓣损害中的作用。在这里,来自RHD患者的抗内皮细胞抗体已被用于刺激EC(HUVEC和HMVEC)。在两个EC中均记录了ECs促炎表型,其中TNFα,IL-6,IL-8,IFNγ,IL-1β,ICAM1,VCAM1,E-选择素,层粘连蛋白B和波形蛋白的表达增加。还观察到各种关键炎症细胞因子(TNFα,IL-6和IL-8),整联蛋白(ICAM1)与白细胞经内皮迁移相关的启动子低甲基化,以及细胞外基质基因(波形蛋白和层粘连蛋白)。此外,体外数据与离体观察结果一致,离体观察结果与诸如吸烟,社会经济地位和住房等病因密切相关。因此,本研究阐明了EC在RHD中的作用,这是阐明疾病发病机理的一步。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号